|
1
|
Belver L and Ferrando A: The genetics and
mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer.
16:494–507. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Richter-Pechańska P, Kunz JB, Hof J,
Zimmermann M, Rausch T, Bandapalli OR, Orlova E, Scapinello G, Sagi
JC, Stanulla M, et al: Identification of a genetically defined
ultra-high-risk group in relapsed pediatric T-lymphoblastic
leukemia. Blood Cancer J. 7:e5232017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khamisipour G, Jadidi-Niaragh F, Jahromi
AS, Zandi K and Hojjat-Farsangi M: Mechanisms of tumor cell
resistance to the current targeted-therapy agents. Tumour Biol.
37:10021–10039. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nencioni A, Cea M, Montecucco F, Longo VD,
Patrone F, Carella AM, Holyoake TL and Helgason GV: Autophagy in
blood cancers: Biological role and therapeutic implications.
Haematologica. 98:1335–1343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Evangelisti C, Evangelisti C, Chiarini F,
Lonetti A, Buontempo F, Neri LM, McCubrey JA and Martelli AM:
Autophagy in acute leukemias: A double-edged sword with important
therapeutic implications. Biochim Biophys Acta. 1853:14–26. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gump JM, Staskiewicz L, Morgan MJ, Bamberg
A, Riches DW and Thorburn A: Autophagy variation within a cell
population determines cell fate through selective degradation of
Fap-1. Nat Cell Biol. 16:47–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lange SS and Vasquez KM: HMGB1: The
jack-of-all-trades protein is a master DNA repair mechanic. Mol
Carcinog. 48:571–580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao
L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and
disease. Mol Aspects Med. 40:1–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bianchi ME and Agresti A: HMG proteins:
Dynamic players in gene regulation and differentiation. Curr Opin
Genet Dev. 15:496–506. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang D, Kang R, Zeh HJ III and Lotze MT:
High-mobility group box 1 and cancer. Biochim Biophys Acta.
1799:131–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu
Y, Xie M, Yin X, Livesey KM, Lotze MT, et al: HMGB1-induced
autophagy promotes chemotherapy resistance in leukemia cells.
Leukemia. 25:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stevens NE, Chapman MJ, Fraser CK, Kuchel
TR, Hayball JD and Diener KR: Therapeutic targeting of HMGB1 during
experimental sepsis modulates the inflammatory cytokine profile to
one associated with improved clinical outcomes. Sci Rep.
7:58502017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee W, Kwon OK, Han MS, Lee YM, Kim SW,
Kim KM, Lee T, Lee S and Bae JS: Role of moesin in HMGB1-stimulated
severe inflammatory responses. Thromb Haemost. 114:350–363. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu B, Wang H, Andersson U and Tracey KJ:
Regulation of HMGB1 release by inflammasomes. Protein Cell.
4:163–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong Q, Xu LH, Xu W, Fang JP and Xu HG:
HMGB1 translocation is involved in the transformation of autophagy
complexes and promotes chemoresistance in leukaemia. Int J Oncol.
47:161–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu L and Yang L: The function and
mechanism of HMGB1 in lung cancer and its potential therapeutic
implications. Oncol Lett. 15:6799–6805. 2018.PubMed/NCBI
|
|
19
|
Livingston JA, Wang WL, Tsai JW, Lazar AJ,
Leung CH, Lin H, Advani S, Daw N, Santiago-O'Farrill J, Hollomon M,
et al: Analysis of HSP27 and the autophagy marker LC3B+
puncta following preoperative chemotherapy identifies high-risk
osteosarcoma patients. Mol Cancer Ther. 17:1315–1323. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gardella S, Andrei C, Ferrera D, Lotti LV,
Torrisi MR, Bianchi ME and Rubartelli A: The nuclear protein HMGB1
is secreted by monocytes via a non-classical, vesicle-mediated
secretory pathway. EMBO Rep. 3:995–1001. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ito I, Fukazawa J and Yoshida M:
Post-translational methylation of high mobility group box 1 (HMGB1)
causes its cytoplasmic localization in neutrophils. J Biol Chem.
282:16336–16344. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Wheeler D, Tang Y, Guo L, Shapiro
RA, Ribar TJ, Means AR, Billiar TR, Angus DC and Rosengart MR:
Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates
nucleocytoplasmic shuttling and release of HMGB1 during
lipopolysaccharide stimulation of macrophages. J Immunol.
181:5015–5023. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsung A, Klune JR, Zhang X, Jeyabalan G,
Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR and Billiar TR:
HMGB1 release induced by liver ischemia involves Toll-like receptor
4 dependent reactive oxygen species production and calcium-mediated
signaling. J Exp Med. 204:2913–2923. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu B, Antoine DJ, Kwan K, Lundbäck P,
Wähämaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J,
et al: JAK/STAT1 signaling promotes HMGB1 hyperacetylation and
nuclear translocation. Proc Natl Acad Sci USA. 111:3068–3073. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livesey KM, Kang R, Vernon P, Buchser W,
Loughran P, Watkins SC, Zhang L, Manfredi JJ, Zeh HJ III, Li L, et
al: p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer
Res. 72:1996–2005. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davis K, Banerjee S, Friggeri A, Bell C,
Abraham E and Zerfaoui M: Poly(ADP-ribosyl)ation of high mobility
group box 1 (HMGB1) protein enhances inhibition of efferocytosis.
Mol Med. 18:359–369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Z, Li L, Chen L, Yuan W, Dong L,
Zhang Y, Wu H and Wang C: PARP-1 mediates LPS-induced HMGB1 release
by macrophages through regulation of HMGB1 acetylation. J Immunol.
193:6114–6123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang M, Liu L, Xie M, Sun X, Yu Y, Kang R,
Yang L, Zhu S, Cao L and Tang D: Poly-ADP-ribosylation of HMGB1
regulates TNFSF10/TRAIL resistance through autophagy. Autophagy.
11:214–224. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bonaldi T, Talamo F, Scaffidi P, Ferrera
D, Porto A, Bachi A, Rubartelli A, Agresti A and Bianchi ME:
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect
it towards secretion. EMBO J. 22:5551–5560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ugrinova I, Pasheva EA, Armengaud J and
Pashev IG: In vivo acetylation of HMG1 protein enhances its binding
affinity to distorted DNA structures. Biochemistry. 40:14655–14660.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Q and Wang Y: HMG modifications and
nuclear function. Biochim Biophys Acta. 1799:28–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Richard SA, Jiang Y, Xiang LH, Zhou S,
Wang J, Su Z and Xu H: Post-translational modifications of high
mobility group box 1 and cancer. Am J Transl Res. 9:5181–5196.
2017.PubMed/NCBI
|
|
33
|
VanPatten S and Al-Abed Y: High mobility
group box-1 (HMGb1): Current wisdom and advancement as a potential
drug target. J Med Chem. 61:5093–5107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ditsworth D, Zong WX and Thompson CB:
Activation of poly(ADP)-ribose polymerase (PARP-1) induces release
of the pro-inflammatory mediator HMGB1 from the nucleus. J Biol
Chem. 282:17845–17854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han W, Sun J, Feng L, Wang K, Li D, Pan Q,
Chen Y, Jin W, Wang X, Pan H and Jin H: Autophagy inhibition
enhances daunorubicin-induced apoptosis in K562 cells. PLoS One.
6:e284912011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livesey KM, Tang D, Zeh HJ and Lotze MT:
Autophagy inhibition in combination cancer treatment. Curr Opin
Investig Drugs. 10:1269–1279. 2009.PubMed/NCBI
|
|
37
|
Laurent G and Jaffrézou JP: Signaling
pathways activated by daunorubicin. Blood. 98:913–924. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen JJ, Wu R, Yang PC, Huang JY, Sher YP,
Han MH, Kao WC, Lee PJ, Chiu TF, Chang F, et al: Profiling
expression patterns and isolating differentially expressed genes by
cDNA microarray system with colorimetry detection. Genomics.
51:313–324. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kudoh K, Ramanna M, Ravatn R, Elkahloun
AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS and Chin KV:
Monitoring the expression profiles of doxorubicin-induced and
doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res.
60:4161–4166. 2000.PubMed/NCBI
|
|
40
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang Z and Klionsky DJ: An overview of the
molecular mechanism of autophagy. Curr Top Microbiol Immunol.
335:1–32. 2009.PubMed/NCBI
|
|
42
|
Jacquin E, Leclerc-Mercier S, Judon C,
Blanchard E, Fraitag S and Florey O: Pharmacological modulators of
autophagy activate a parallel noncanonical pathway driving
unconventional LC3 lipidation. Autophagy. 13:854–867. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kang R, Zhang Q, Zeh HJ III, Lotze MT and
Tang D: HMGB1 in cancer: Good, bad, or both? Clin Cancer Res.
19:4046–4057. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bell CW, Jiang W, Reich CF III and
Pisetsky DS: The extracellular release of HMGB1 during apoptotic
cell death. Am J Physiol Cell Physiol. 291:C1318–C1325. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tang D, Kang R, Livesey KM, Cheh CW,
Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ III
and Lotze MT: Endogenous HMGB1 regulates autophagy. J Cell Biol.
190:881–892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang D, Kang R, Cheh CW, Livesey KM, Liang
X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, et
al: HMGB1 release and redox regulates autophagy and apoptosis in
cancer cells. Oncogene. 29:5299–5310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhan Z, Li Q, Wu P, Ye Y, Tseng HY, Zhang
L and Zhang XD: Autophagy-mediated HMGB1 release antagonizes
apoptosis of gastric cancer cells induced by vincristine via
transcriptional regulation of Mcl-1. Autophagy. 8:109–121. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Luo J, Chen J and He L: mir-129-5p
attenuates irradiation-induced autophagy and decreases
radioresistance of breast cancer cells by targeting HMGB1. Med Sci
Monit. 21:4122–4129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hu YH, Yang L and Zhang CG: HMGB1-a as
potential target for therapy of hematological malignancies.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:560–564. 2014.(In Chinese).
PubMed/NCBI
|
|
50
|
Tang D, Kang R, Livesey KM, Kroemer G,
Billiar TR, Van Houten B, Zeh HJ III and Lotze MT: High-mobility
group box 1 is essential for mitochondrial quality control. Cell
Metab. 13:701–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sterner R, Vidali G and Allfrey VG:
Studies of acetylation and deacetylation in high mobility group
proteins. Identification of the sites of acetylation in HMG-1. J
Biol Chem. 254:11577–11583. 1979.PubMed/NCBI
|
|
52
|
Pan PH, Cardinal J, Li ML, Hu CP and Tsung
A: Interferon regulatory factor-1 mediates the release of high
mobility group box-1 in endotoxemia in mice. Chin Med J (Engl).
126:918–924. 2013.PubMed/NCBI
|
|
53
|
Dhupar R, Klune JR, Evankovich J, Cardinal
J, Zhang M, Ross M, Murase N, Geller DA, Billiar TR and Tsung A:
Interferon regulatory factor 1 mediates acetylation and release of
high mobility group box 1 from hepatocytes during murine liver
ischemia-reperfusion injury. Shock. 35:293–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hassa PO, Haenni SS, Elser M and Hottiger
MO: Nuclear ADP-ribosylation reactions in mammalian cells: Where
are we today and where are we going? Microbiol Mol Biol Rev.
70:789–829. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vadillo E, Dorantes-Acosta E, Pelayo R and
Schnoor M: T cell acute lymphoblastic leukemia (T-ALL): New
insights into the cellular origins and infiltration mechanisms
common and unique among hematologic malignancies. Blood Rev.
32:36–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yuan T, Yang Y, Chen J, Li W, Li W, Zhang
Q, Mi Y, Goswami RS, You JQ, Lin D, et al: Regulation of PI3K
signaling in T cell acute lymphoblastic leukemia: A novel
PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role
for PIK3CD. Leukemia. 31:2355–2364. 2017. View Article : Google Scholar : PubMed/NCBI
|
